Fluoroquinolone resistance in Streptococcus pneumoniae in United States since 1994-1995.

Fluoroquinolone resistance in Streptococcus pneumoniae in United States since 1994-1995.

The in vitro activities of ciprofloxacin, levofloxacin, gatifloxacin, and moxifloxacin against a large collection of clinical isolates of Streptococcus pneumoniae (n = 4,650) obtained over a 5-year period, 1994-1995 through 1999-2000, were assessed as part of a longitudinal multicenter U.S. surveill...

Full description

Bibliographic Details
Main Authors:	Brueggemann, A, Coffman, S, Rhomberg, P, Huynh, H, Almer, L, Nilius, A, Flamm, R, Doern, G
Format:	Journal article
Language:	English
Published:	2002

Similar Items

Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999--2000, including a comparison of resistance rates since 1994--1995.
by: Doern, G, et al.
Published: (2001)

The molecular epidemiology of penicillin-resistant Streptococcus pneumoniae in the United States, 1994-2000.
by: Richter, S, et al.
Published: (2002)

Prevalence of macrolide resistance mechanisms in Streptococcus pneumoniae isolates from a multicenter antibiotic resistance surveillance study conducted in the United States in 1994-1995.
by: Shortridge, V, et al.
Published: (1999)

Antimicrobial Resistance with Streptococcus pneumoniae in the United States, 1997–98
by: Gary V. Doern, et al.
Published: (1999-12-01)

Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study.
by: Doern, G, et al.
Published: (1996)

Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997 98.
by: Doern, G, et al.
Published: (1999)

In vitro activity of ABT-773, a new ketolide, against recent clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.
by: Brueggemann, A, et al.
Published: (2000)

The prevalence of fluoroquinolone resistance among clinically significant respiratory tract isolates of Streptococcus pneumoniae in the United States and Canada--1997 results from the SENTRY Antimicrobial Surveillance Program.
by: Doern, G, et al.
Published: (1998)

In vitro activity of BAY 12-8039, a novel 8-methoxyquinolone, compared to activities of six fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.
by: Brueggemann, A, et al.
Published: (1997)

Molecular characterization of the beta-lactamases from clinical isolates of Moraxella (Branhamella) catarrhalis obtained from 24 U.S. medical centers during 1994-1995 and 1997-1998.
by: Richter, S, et al.
Published: (2000)

Resistance among Streptococcus pneumoniae: Patterns, mechanisms, interpreting the breakpoints
by: Brueggemann, A, et al.
Published: (2000)

Resistance among Streptococcus pneumoniae: patterns, mechanisms, interpreting the breakpoints.
by: Brueggemann, A, et al.
Published: (2000)

Resistance among Streptococcus pneumoniae: Patterns, mechanisms, interpreting the breakpoints
by: Brueggemann, A, et al.
Published: (2000)

Antimicrobial-drug use and changes in resistance in Streptococcus pneumoniae.
by: Diekema, D, et al.
Published: (2000)

Fluoroquinolone-resistant Streptococcus pneumoniae
by: Mathias W. Pletz, et al.
Published: (2006-09-01)

Assessment of the oxacillin disk screening test for determining penicillin resistance in Streptococcus pneumoniae.
by: Doern, G, et al.
Published: (1997)

A 1997-1998 national surveillance study: Moraxella catarrhalis and Haemophilus influenzae antimicrobial resistance in 34 US institutions.
by: Richter, S, et al.
Published: (1999)

Antimicrobial-Drug Use and Changes in Resistance in Streptococcus pneumoniae
by: Daniel J. Diekema, et al.
Published: (2000-10-01)

Relative Fitness of Fluoroquinolone-resistant Streptococcus pneumoniae
by: Crystal N. Johnson, et al.
Published: (2005-06-01)

У STREPTOCOCCUS PNEUMONIAE. INSIGHTS INTO THE EVOLUTIONARY TRAJECTORIES OF FLUOROQUINOLONE RESISTANCE IN STREPTOCOCCUS PNEUMONIAE
by: G. .. Zhang, et al.
Published: (2020-05-01)

Prevalence of antimicrobial resistance among 723 outpatient clinical isolates of Moraxella catarrhalis in the United States in 1994 and 1995: results of a 30-center national surveillance study.
by: Doern, G, et al.
Published: (1996)

Molecular Analysis of Rising Fluoroquinolone Resistance in Belgian Non-Invasive Streptococcus pneumoniae Isolates (1995-2014).
by: Pieter-Jan Ceyssens, et al.
Published: (2016-01-01)

Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study.
by: Doern, G, et al.
Published: (1997)

Use of penicillin MICs to predict in vitro activity of other beta-lactam antimicrobial agents against Streptococcus pneumoniae.
by: Brueggemann, A, et al.
Published: (2001)

Assessment of laboratory performance with Streptococcus pneumoniae antimicrobial susceptibility testing in the United States: a report from the College of American Pathologists Microbiology Proficiency Survey Program.
by: Doern, G, et al.
Published: (1999)

Clonal relationships among high-level penicillin-resistant Streptococcus pneumoniae in the United States.
by: Doern, G, et al.
Published: (1998)

In vitro activity of sanfetrinem (GV104326), a new trinem antimicrobial agent, versus Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.
by: Doern, G, et al.
Published: (1996)

Fluoroquinolone Resistance in Penicillin-resistant Streptococcus pneumoniae Clones, Spain
by: Adela G. de la Campa, et al.
Published: (2004-10-01)

Streptococcus pneumoniae, Brooklyn, New York: Fluoroquinolone Resistance at our Doorstep
by: John Quale, et al.
Published: (2002-06-01)

Emergence of fluoroquinolone-resistant Streptococcus pneumoniae in Lebanon: A report of three cases
by: Mazen R. Naba, et al.
Published: (2010-09-01)

Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae from Asian countries: ANSORP study
by: Oh, W.S., et al.
Published: (2004)

Streptococcus pneumoniae favors tolerance via metabolic adaptation over resistance to circumvent fluoroquinolones
by: Tina H. Dao, et al.
Published: (2024-02-01)

Changes in Fluoroquinolone-Resistant Streptococcus pneumonia after 7-Valent Conjugate Vaccination, Spain
by: Adela G. de la Campa, et al.
Published: (2009-06-01)

Host Cell Oxidative Stress Promotes Intracellular Fluoroquinolone Persisters of Streptococcus pneumoniae
by: Mirelys Hernandez-Morfa, et al.
Published: (2022-12-01)

Intracellular Streptococcus pneumoniae develops enhanced fluoroquinolone persistence during influenza A coinfection
by: Mirelys Hernandez-Morfa, et al.
Published: (2024-07-01)

Antibacterial activity of a DNA topoisomerase I inhibitor versus fluoroquinolones in Streptococcus pneumoniae.
by: Myriam V Valenzuela, et al.
Published: (2020-01-01)

In vitro activity of fluoroquinolones (gatifloxacin, levofloxacin and trovafloxacin) and seven other antibiotics against Streptococcus pneumoniae
by: Nicodemo A.C., et al.
Published: (2001-01-01)

In vitro activity of fluoroquinolones (gatifloxacin, levofloxacin and trovafloxacin) and seven other antibiotics against Streptococcus pneumoniae
by: A.C. Nicodemo, et al.

Antimicrobial Susceptibility Breakpoints and First-Step parC Mutations in Streptococcus pneumoniae: Redefining Fluoroquinolone Resistance
by: Sue Lim, et al.
Published: (2003-07-01)

Geographic distribution and clonal diversity of Streptococcus pneumoniae serotype 1 isolates.
by: Brueggemann, A, et al.
Published: (2003)